Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement.

Köhler, Thomas; Schwier, Elke; Henzler, Dietrich; Eickmeyer, Claas

Köhler, Thomas; Schwier, Elke; Henzler, Dietrich; Eickmeyer, Claas.

Köhler T; Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr University Bochum, Klinikum Herford, Herford, Germany. Electronic address: Thomas.Koehler@ruhr-uni-bochum.de.
Schwier E; Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr University Bochum, Klinikum Herford, Herford, Germany.
Henzler D; Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr University Bochum, Klinikum Herford, Herford, Germany.
Eickmeyer C; Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr University Bochum, Klinikum Herford, Herford, Germany.

J Crit Care ; 66: 187-188, 2021 12.

Article in English | MEDLINE | ID: covidwho-1333562

Subject(s)

COVID-19; Extracorporeal Membrane Oxygenation; Hemoperfusion; Cytokines; Humans; SARS-CoV-2

Keywords

COVID-19; ECMO; Hemoadsorption; Interleukin-6

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Extracorporeal Membrane Oxygenation / Hemoperfusion / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: J Crit Care Journal subject: Critical Care Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google